Grape seed extract shows promise for mild hypertension
NCT ID NCT06982365
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a grape seed extract supplement called Enovita can lower blood pressure in adults with elevated blood pressure or stage 1 hypertension. Eighty participants took either the supplement or a placebo twice daily for 8 weeks. Researchers measured changes in blood pressure, mood, stress, and inflammation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- grape seed extract (Enovita)
- What this could lead to
- If it works, this could offer a natural supplement option to help manage early high blood pressure.
- What could go wrong
- This is a small, short-term study (80 people, 8 weeks). Results may not apply to everyone, and supplements are not a substitute for prescribed medication.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELEVATED BLOOD PRESSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Liaquat University of Medical & Health Sciences (LUMHS)
Jāmshoro, Sindh, 76090, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Chatbot could put blood pressure control in Patients' hands
- Can a 5-Step chat help tame high blood pressure?
- Can artery scans reveal hidden damage from high blood pressure?
- CRISPR injection could rewrite the future of blood pressure control
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?